There is one clinical trial.
Our hypothesis was that physical activity program will be acceptable and may counteract physical and mental decline among older adults hospitalized in covid-19 unit
Description: adherence of the intervention evaluated by the number of completed exercise days compared to the number of total intervention daysMeasure: Change of adherence of the intervention Time: through study completion, an average of 15 days
Description: Comparison between inclusion and final physical performances measured by the 30-second chair test, balance with joint-feet, semi-tandem stance, 4 meters comfortable walking test, functional abilities with the evaluation of ADL score and HAD scores.Measure: Change of physical performances Time: through study completion, an average of 15 days
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports